| Authors: |
Fleming K; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Burley K; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Ponce-Garcia F; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Akbari P; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Wort's Causeway, Cambridge, UK.; Department of Human Genetics, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Naveh C; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Rice C; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Zakrzewski P; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Gibbs W; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Groves S; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Cela D; The Francis Crick Institute, Antimicrobial Defence Laboratory, London, UK., Papayannopoulos V; The Francis Crick Institute, Antimicrobial Defence Laboratory, London, UK., Harbort CJ; Cellular Microbiology, Max Planck Institute for Infection Biology, Chariteplatz 1, Berlin, Germany., Mumford A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Amulic B; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK. |
